Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bazarbachi

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Current Research in Translational Medicine|October 10, 2017
Fludarabine-based reduced intensity regimen for matched related donor hematopoietic stem cell transplantation in acquired severe aplastic anemiaK M Ghanem, M A Kharfan-Dabaja, H El-Solh, et al.
British Journal of Haematology|November 5, 1997
Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international studyA Bazarbachi, V Soriano, R Pawson, et al.
Bone Marrow Transplantation|November 29, 2016
Veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic stem cell transplantation: Middle East/North Africa regional consensus on prevention, diagnosis and managementA H Al Jefri, H Abujazar, A Al-Ahmari, et al.
Annales De Medecine Interne|January 1, 1996
[Difference in costs of autologous transplantation of peripheral and bone marrow hematopoietic stem cells. A retrospective analysis over 1 year of transplantation in lymphoma, Hodgkin's disease and myeloma in a Center]B Rio, Z Marjanovic, R Belhocine, et al.
Leukemia|June 15, 2007
PS-341 or a combination of arsenic trioxide and interferon-alpha inhibit growth and induce caspase-dependent apoptosis in KSHV/HHV-8-infected primary effusion lymphoma cellsR Abou-Merhi, R Khoriaty, D Arnoult, et al.
Bone Marrow Transplantation|July 1, 2014
Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMTM A Kharfan-Dabaja, M Labopin, A Bazarbachi, et al.
Current Research in Translational Medicine|July 9, 2017
How to prevent relapse after allogeneic hematopoietic stem cell transplantation in patients with acute leukemia and myelodysplastic syndromeN Yafour, F Beckerich, C E Bulabois, et al.
Leukemia|April 14, 2000
Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphomaA Bazarbachi, R Nasr, M E El-Sabban, et al.
Oncogene|September 25, 2007
Ubiquitylated Tax targets and binds the IKK signalosome at the centrosomeY Kfoury, R Nasr, A Favre-Bonvin, et al.
Bone Marrow Transplantation|April 2, 2013
Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failureM Ayas, A Nassar, A A Hamidieh, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Current Research in Translational Medicine|October 10, 2017
Fludarabine-based reduced intensity regimen for matched related donor hematopoietic stem cell transplantation in acquired severe aplastic anemiaK M Ghanem, M A Kharfan-Dabaja, H El-Solh, et al.
British Journal of Haematology|November 5, 1997
Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international studyA Bazarbachi, V Soriano, R Pawson, et al.
Bone Marrow Transplantation|November 29, 2016
Veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic stem cell transplantation: Middle East/North Africa regional consensus on prevention, diagnosis and managementA H Al Jefri, H Abujazar, A Al-Ahmari, et al.
Annales De Medecine Interne|January 1, 1996
[Difference in costs of autologous transplantation of peripheral and bone marrow hematopoietic stem cells. A retrospective analysis over 1 year of transplantation in lymphoma, Hodgkin's disease and myeloma in a Center]B Rio, Z Marjanovic, R Belhocine, et al.
Leukemia|June 15, 2007
PS-341 or a combination of arsenic trioxide and interferon-alpha inhibit growth and induce caspase-dependent apoptosis in KSHV/HHV-8-infected primary effusion lymphoma cellsR Abou-Merhi, R Khoriaty, D Arnoult, et al.
Bone Marrow Transplantation|July 1, 2014
Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMTM A Kharfan-Dabaja, M Labopin, A Bazarbachi, et al.
Current Research in Translational Medicine|July 9, 2017
How to prevent relapse after allogeneic hematopoietic stem cell transplantation in patients with acute leukemia and myelodysplastic syndromeN Yafour, F Beckerich, C E Bulabois, et al.
Leukemia|April 14, 2000
Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphomaA Bazarbachi, R Nasr, M E El-Sabban, et al.
Oncogene|September 25, 2007
Ubiquitylated Tax targets and binds the IKK signalosome at the centrosomeY Kfoury, R Nasr, A Favre-Bonvin, et al.
Bone Marrow Transplantation|April 2, 2013
Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failureM Ayas, A Nassar, A A Hamidieh, et al.
Pageof 6